NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock - Currency: USD
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Hologic (NASDAQ:HOLX) and its peers.
Hologic declined a $16 billion buyout bid from TPG and Blackstone as it faces falling shares and tariff-related headwinds, leaving room for deal talks to potentially resume.
Mentions: BX
Wall Street charged higher Tuesday, with U.S. equities posting broad-based gains by midday as investors embraced a risk-on mood, spurred by easing Treasury yields and renewed optimism surrounding trade talks between the U.S. and the European Union.
Shares of medical technology company Hologic (NASDAQ:HOLX) jumped 18.6% in the afternoon session after the Financial Times reported that private equity firms TPG and Blackstone made an offer to buy the company (HOLX).
The women's health market is booming, with Hologic and Quest Diagnostics leading the charge. But which one stands out more for investors today?
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
President Trump has been pushing for lower interest rates. If this happens, there could be ripple effects across the economy. Here's how retirees could benefit.
Evaluate Hologic's (HOLX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
HOLX displays cautious fiscal 2025 guidance in a challenging geopolitical and macroeconomic environment. What does it mean for the stock?
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
HOLX delivers earnings and revenue beat in the second quarter of fiscal 2025 amid macroeconomic turbulence.
While the top- and bottom-line numbers for Hologic (HOLX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.